PRESS RELEASE published on 04/20/2026 at 15:56, 3 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.61% interest in Spire Healthcare Group plc through 14,524,701 securities. Purchase of 8,730 securities at 1.64 GBP per unit Securities Vanguard Group Purchase Interest Spire Healthcare Group Plc
PRESS RELEASE published on 04/20/2026 at 15:55, 3 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Senior plc The Vanguard Group, Inc. discloses a 5.14% stake in Senior plc as of 17 April 2026. Details on relevant securities and dealings provided Disclosure The Vanguard Group Dealings Stake Senior Plc
PRESS RELEASE published on 04/20/2026 at 15:54, 3 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses a 2.56% interest in Schroders plc. Details of ownership and positions revealed in Form 8.3 Securities Form 8.3 The Vanguard Group Schroders Plc Interests
PRESS RELEASE published on 04/20/2026 at 15:54, 3 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses 5.05% interest in Picton Property Income Limited. Deals in ordinary NPV shares on 17 April 2026 Shares Disclosure The Vanguard Group Interest Picton Property Income Limited
PRESS RELEASE published on 04/20/2026 at 15:53, 3 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses ownership of 5.33% stake in NCC Group plc. Details of securities and transactions provided in Form 8.3 The Vanguard Group, Inc. Form 8.3 Ownership Stake NCC Group Plc
PRESS RELEASE published on 04/20/2026 at 15:52, 3 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses 5.09% stake in JTC plc with 8,766,337 shares. Purchase of 5,280 shares at 13.15 GBP per unit. Disclosure made on 20 April 2026 The Vanguard Group, Inc. Stock Purchase Share Disclosure Stake Percentage JTC Plc
PRESS RELEASE published on 04/20/2026 at 15:51, 3 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc The Vanguard Group, Inc. discloses 5.60% ownership in Intertek Group plc as of 17th April 2026 in accordance with Rule 8.3 of the Takeover Code The Vanguard Group, Inc. Rule 8.3 Takeover Code Ownership Disclosure Intertek Group Plc
PRESS RELEASE published on 04/20/2026 at 15:50, 3 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc The Vanguard Group, Inc. discloses a 1.33% stake in International Personal Finance plc through 2,926,332 shares. Purchased 8,821 shares at 2.47 GBP each on 17 April 2026 Shares Vanguard Group Purchase Stake International Personal Finance Plc
PRESS RELEASE published on 04/20/2026 at 15:50, 3 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Gamma Communications plc The Vanguard Group, Inc. discloses a 1.41% interest in Gamma Communications plc as of 17 April 2026. Purchased 4,150 securities at 9.13 GBP per unit Securities Disclosure Vanguard Group Inc. Purchase Gamma Communications PLC
PRESS RELEASE published on 04/20/2026 at 15:49, 3 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The The Vanguard Group, Inc. discloses a 5.56% stake in British Land Company plc. Details of stock purchases revealed in Form 8.3 filing Form 8.3 Disclosure Vanguard Group Stock Purchases British Land Company
Published on 08/19/2026 at 13:00, 1 hour 32 minutes ago UraniumX Discovery Corp. Provides Update On Transaction With Pond Technologies Holdings INC.
Published on 08/19/2026 at 13:00, 1 hour 32 minutes ago Abasca Announces Positive Preliminary Economic Assessment for the Loki Flake Graphite Deposit: After-Tax NPV of US$130 Million and 16.7% IRR
Published on 08/19/2026 at 12:30, 2 hours 2 minutes ago Wolfden Announces Positive Precious Metal Results at Canoe Landing
Published on 08/19/2026 at 09:05, 5 hours 27 minutes ago BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies
Published on 08/19/2026 at 07:00, 7 hours 32 minutes ago Caldwell Strengthens Life Sciences and Healthcare Practice with Addition of Olga Kozlova in Dubai
Published on 08/19/2026 at 14:11, 20 minutes ago Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 3rd Interim Report and Final Report
Published on 08/19/2026 at 14:05, 26 minutes ago Harvey taps DeepL to power legal-grade AI translation for global law firms and legal teams
Published on 08/19/2026 at 13:37, 55 minutes ago Nebius Group announces proposed private offering of $4.50 billion of convertible senior notes
Published on 08/19/2026 at 13:30, 1 hour 2 minutes ago Nexum Group AG Appoints Sebastian Holl as Chief Financial Officer
Published on 08/19/2026 at 13:21, 1 hour 10 minutes ago Original-Research: PNE AG (von First Berlin Equity Research GmbH): Buy
Published on 08/18/2026 at 18:00, 20 hours 32 minutes ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 20 hours 47 minutes ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 3 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 3 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 18 hours ago Aéroports de Paris S.A - July 2026 traffic figures
